Results 1 to 10 of about 784,229 (242)

Cost-effectiveness of a proactive, integrated primary care approach for community-dwelling frail older persons

Cost Effectiveness and Resource Allocation, 2019
Background The article reports on the cost-effectiveness of the proactive, integrated primary care program Finding and Follow-up of Frail older persons (FFF) compared with usual primary care for community-dwelling frail older persons in the Netherlands ...
Lotte Vestjens, Jane M. Cramm, Erwin Birnie, Anna P. Nieboer   +3 more
doaj   +1 more source

Biosimilar medicines and cost-effectiveness

ClinicoEconomics and Outcomes Research, 2011
Steven SimoensResearch Centre for Pharmaceutical Care and Pharmaco-economics, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumAbstract: Given that biosimilars are agents that are similar but not identical to the ...
Steven Simoens
doaj  

Rapid Health Technology Assessment in Rehabilitation Hospital: Review Article

مجله دانشکده پزشکی اصفهان, 2013
Background: Medical advances, improved health status, and increased longevity have led to increased elderly in the society; therefore, the role of rehabilitation centers in the service industry has grown considerably in the two past decades.
Sheila Doaee, Mohamadreza Mobinizadeh, Alireza Oliyaeemanesh   +2 more
doaj  

Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS

Diabetes, Metabolic Syndrome and Obesity, 2011
Przemyslaw Holko, Pawal KawalecHTA Centre, Kraków, PolandAims: This study assessed the cost efficacy and cost utility of the automatic blood glucose meter CONTOUR® TS from the public payer (National Health Fund [NHF]) and payer ...
Przemyslaw Holko, Pawal Kawalec
doaj  

Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

International Journal of COPD, 2010
Anand A Dalal1, Meaghan St Charles2, Hans V Petersen2, Melissa H Roberts2, Christopher M Blanchette2, Kathy Manavi-Zieverink31US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, 2Division of Clinical and Outcomes Research, Lovelace ...
An, A Dalal, Meaghan St Charles, Hans V Petersen, et al   +4 more
doaj  

Efficiency of hospitals in COVID-19 era: a case study of an affected country

Cost Effectiveness and Resource Allocation
Background The COVID-19 pandemic has affected all aspects of human life and society and has damaged the global economy. Health systems and hospitals were not exempted from this situation.
Anita Hamdollahzadeh, Bahram Nabilou, Hasan Yusefzadeh   +2 more
doaj   +1 more source

The effect of hospital budgeting system on physician-executives’ budget cognitive consciousness and medical decision making

Cost Effectiveness and Resource Allocation
Background and objective This study adopts social cognitive theory to comprehensively explore how hospital budgeting systems influence physician-executives' budget cognitions (budget usefulness, relevance, and cost control consciousness) and how these ...
Wen-Hsin Huang, Cheng-Tsung Lu
doaj   +1 more source

Health economic evaluation of trans-tibial prosthetic suspension systems: a protocol for a pilot using an observational study and synthetic cohort

Cost Effectiveness and Resource Allocation
Background Health Economic Evaluations (HEEs) provide the necessary evidence of cost–benefit to inform policy and investment decisions. No HEEs have quantified the cost–benefit of passive suction (PS) vs vacuum assisted suction (VAS) suspension for trans-
Leigh Clarke, Alan Shiell, Michael P. Dillon   +2 more
doaj   +1 more source

A systematic review of the current application status of decision-analytical models in the pharmacoeconomic evaluation of targeted therapies for pulmonary arterial hypertension

Cost Effectiveness and Resource Allocation
Background The implementation of targeted drug therapy results in a significant improvement in both survival rates and quality of life among patients diagnosed with pulmonary arterial hypertension (PAH), concurrently imposing a greater financial burden ...
Wenxing Dong, Zhe Zhang, Xiaodan Wang, Xiaolong Ma, Mingming Chu, Yulian Li, Xing Xiang, Cheng Peng, Rong Zhang   +8 more
doaj   +1 more source

Direct medical cost analysis of breast cancer treatment at Jimma University Medical Center: a provider perspective

Cost Effectiveness and Resource Allocation
Introduction Breast cancer is an evolving non-communicable disease and a global disease burden, which accounts for a momentous portion of worldwide mortality and morbidity with significant economic impacts.
Gebeyehu Jeldu Edessa, Kidist Adamu Kare, Aleka Jeldu Edessa, Dawit Wolde Daka   +3 more
doaj   +1 more source